A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...

As with MCN, patients with borderline tumors or carcinoma in situ are usually cured. With invasive carcinoma, the 5 and 10-year survival is 60% and 50% which is much better than typical pancreatic ...

The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing ...

A new blood test could help doctors detect pancreatic cancer earlier, potentially improving survival rates for one of the deadliest cancers.

Pancreatic cancer is a disease in which malignant cells originate in the pancreatic tissue. Cancer of the exocrine component of the pancreas (adenocarcinomas) represents the majority of pancreatic ...